These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors. Hanna WT, Madigan RR, Miles MA, Lange RD. Thromb Haemost; 1981 Oct; 46(3):638-41. PubMed ID: 6976016 [Abstract] [Full Text] [Related]
11. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. Br J Haematol; 2006 Jun 05; 133(6):591-605. PubMed ID: 16704433 [Abstract] [Full Text] [Related]
13. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B. Torghabeh HM, Pourfathollah A, Shooshtari MM, Yazdi ZR. Iran J Allergy Asthma Immunol; 2006 Mar 05; 5(1):33-4. PubMed ID: 17242502 [Abstract] [Full Text] [Related]
16. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII. Kantrowitz JL, Lee ML, McClure DA, Kingdon HS, Thomas WR. Clin Ther; 1987 Mar 05; 9(4):405-19. PubMed ID: 3111706 [Abstract] [Full Text] [Related]
17. Clinicohaematological profile of two cases of inhibitors to factor VIII. Shanthala Devi AM, Srikrishna A, Sitalaksmi S, Damodar P. Indian J Pathol Microbiol; 2001 Jul 05; 44(3):365-6. PubMed ID: 12024937 [Abstract] [Full Text] [Related]
19. [Development of factor VIII inhibitor in three non-hemophiliac patients]. Kiguchi T, Niiya K, Yamawaki Y, Shima M, Harada M. Rinsho Ketsueki; 2000 Nov 05; 41(11):1195-200. PubMed ID: 11193439 [Abstract] [Full Text] [Related]